详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

The promising therapeutic agents for heart diseases: Histone Methyltransferase inhibitors

73| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China [2]Key Laboratory of Organ Transplantation, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China [3]Key Laboratory of Organ Transplantation, Ministry of Health, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

出处：

DOI：

ISSN：

关键词： Heart disease Epigenetics Histone Methyltransferase Inhibitor

基金：

基金编号： 81600188 2016CFB162 2042016kf0074 2016YQ02

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2016]版：

大类 | 2 区医学

小类 | 2 区心脏和心血管系统

最新[2025]版：

大类 | 2 区医学

小类 | 3 区心脏和心血管系统

JCR分区：

出版当年[2015]版：

Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

最新[2023]版：

Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子： 3.2 最新[2023版] 3.2 最新五年平均 4.638 出版当年[2015版] 4.468 出版当年五年平均 4.036 出版前一年[2014版] 6.189 出版后一年[2016版]

第一作者：

第一作者单位： [1]Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China [2]Key Laboratory of Organ Transplantation, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China [3]Key Laboratory of Organ Transplantation, Ministry of Health, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

通讯作者：

通讯机构： [1]Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China [*1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Key Lab Organ Transplantat,Minist Hlth,Div Cardio, 1095 Jiefang Ave, Wuhan 430030, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Histone lysine methylation and congenital heart disease: From bench to bedside [2]Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts [3]Histone methyltransferase SMYD2: ubiquitous regulator of disease [4]Loss of histone lysine methyltransferase EZH2 confers resistance to tyrosine kinase inhibitors in non-small cell lung cancer [5]Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer [6]The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease [7]Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer [8]Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges [9]The Histone Methyltransferase Mixed Lineage Leukemia (MLL) 3 May Play a Potential Role in Clinical Dilated Cardiomyopathy [10]Epigenetics in diabetic cardiomyopathy